Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-01

FDA Approved: DESLORATADINE — Supplemental Application (Virtus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for desloratadine from Virtus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

SUPPL AP for DESLORATADINE (DESLORATADINE)